| All patients | Group S | Group N |
|
| n = 305 | n = 58 | n = 247 | P-value |
Characteristics |
|
|
|
|
Age (years) | 49.4 ± 14.7 | 45.28 ± 15.35 | 50.3 ± 14.5 | 0.020 |
Male | 210 (68.9%) | 36 (62.1%) | 174 (70.5%) | 0.215 |
Body surface area (cm2) | 2.03 ± 0.3 | 2.01 0.32 | 2.03 ± 0.30 | 0.652 |
Body mass index | 31.35 ± 9.95 | 31.93 ± 10.20 | 31.21 ± 9.87 | 0.62 |
Underlying Conditions |
|
|
|
|
Smoking | 103 (34%) | 16 (28%) | 87 (35%) | 0.268 |
Coronary artery disease | 106 (35%) | 15 (26%) | 91 (37%) | 0.214 |
Chronic lung disease | 55 (18%) | 13 (22%) | 42 (17%) | 0.335 |
Diabetes | 74 (24%) | 10 (17%) | 64 (26%) | 0.166 |
Liver failure | 24 (8%) | 10 (17%) | 42 (6%) | 0.003 |
Chronic immunosuppression | 35 (11%) | 7 (12%) | 64 (11%) | 0.875 |
Cardiogenic shock | 194 (64%) | 30 (52%) | 164 (66%) | 0.037 |
Mode of ECMO |
|
|
|
|
Veno-arterial ECMO | 211 (69%) | 33 (57%) | 186 (75%) | 0.005 |
Veno-veno ECMO | 94 (30%) | 25 (43%) | 61 (25%) | 0.005 |